RecruitingNot ApplicableNCT05817825

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD

Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With Opioid Use Disorder Hospitalized With Serious Injection-related Infection

Sponsor

Brigham and Women's Hospital

Enrollment

20 participants

Start Date

Nov 17, 2023

Study Type

INTERVENTIONAL

Conditions

serious bacterial infections Opioid-use Disorder

Summary

This study aims to test a remotely delivered IOP program ("SmartIOP") for OUD patients who are hospitalized for serious injection-related infections. This will be a pilot trial to assess the feasibility of the IOP program and examine OUD-related outcomes following discharge from the hospital.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This pilot study tests a new remotely delivered intensive outpatient program (IOP) for people with opioid use disorder (OUD) who are transitioning out of hospital. Traditional IOPs require in-person attendance multiple times a week — a significant barrier for people who lack transportation, live far from treatment centers, or face unstable housing. A telehealth-based IOP could remove those barriers and reach people who would otherwise not receive structured addiction treatment. Eligible participants are English-speaking adults 18 and older with any DSM-5 substance use disorder who are able to consent and can identify at least two people who can serve as emergency contacts after hospital discharge. Those with psychotic disorders, active suicidality or homicidality, or a terminal condition are excluded. Enrolled participants engage in the remote IOP through video sessions and digital tools and are followed to assess feasibility, engagement, and treatment outcomes. Opioid use disorder remains a devastating public health crisis, and the gap between hospital discharge and ongoing treatment is one of the highest-risk periods for relapse and overdose. This study could validate a scalable model for bridging that gap remotely, meeting patients wherever they are and providing the structured support needed to sustain recovery.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSmart IOP Intervention

Smart IOP is a remotely delivered IOP program in operation since 2016, allowing patients to complete addiction treatment entirely online. The original program, consisting of 72 video modules across 8 different topics, will be adapted and tailored to hospitalized patients with serious infections from injection drug use. Participants will watch video content asynchronously, and will be required to correctly answer knowledge questions to proceed to the next module. The whole treatment program will require approximately 4 weeks to complete. Participants are also asked to answer questions about how to apply the knowledge to their own personal circumstances. The answers to these are reviewed by the peer recovery coach during weekly encounters. Videos can be viewed at a time that is most convenient to the participants. T

BEHAVIORALPeer Recovery Coach

Peer recovery coach, an individual in sustained recovery (\>5 years) and certified to be a coach, will meet weekly with the participant to review progress, answer questions about the videos, review answers to questions, and encourage continuation of treatment after discharge. These meetings will occur in-person or remotely.